[ExI] Reprogramming cancer cells
Stuart LaForge
avant at sollegro.com
Sun Dec 29 05:13:56 UTC 2024
On 2024-12-28 21:04, Stuart LaForge wrote:
> These researchers at the bioengineering departments at the Korea
> Advanced Institute of Science and Technology used computational biology
> techniques to develop a Boolean model of gene regulatory networks in
> cells they call BENEIN. They then used it on human large intestinal
> single-cell transcriptome data to identify three genes MYB, HDAC2, and
> FOXA2 as "master regulatory genes" for differentiation into normal
> intestinal cells. Then they claim that they took three different colon
> cancer cell lines and by knocking down, i.e. shutting off those three
> genes, made the cancer cells back phenotypically normal large intestine
> cells.
>
> https://onlinelibrary.wiley.com/doi/10.1002/advs.202402132
>
> ---------Excerpt------------------
>
> Control of Cellular Differentiation Trajectories for Cancer Reversion
> Jeong-Ryeol Gong, Chun-Kyung Lee, Hoon-Min Kim, Juhee Kim, Jaeog Jeon,
> Sunmin Park,and Kwang-Hyun Cho*
>
> Abstract:
> Cellular differentiation is controlled by intricate layers of gene
> regulation, involving the modulation of gene expression by various
> transcriptional regulators. Due to the complexity of gene regulation,
> identifying master regulators across the differentiation trajectory has
> been a longstanding challenge. To tackle this problem, a computational
> framework, single-cell Boolean network inference and control (BENEIN),
> is presented. Applying BENEIN to human large intestinal single-cell
> transcriptome data, MYB,HDAC2, and FOXA2 are identified as the master
> regulators whose inhibition induces enterocyte differentiation. It is
> found that simultaneous knockdown of these master regulators can revert
> colorectal cancer cells into normal-like enterocytes by synergistically
> inducing differentiation and suppressing malignancy, which is validated
> by in vitro and in vivo experiments.
>
> --------------------------------------
>
> Note that that they use "in vivo" in a biochemical sense which means
> inside a living cell and not medical "in vivo" which means inside an
> intact organism like a mouse or human.
>
> Stuart LaForge
Well ok. They did use grafts of the cell lines into nude mice, but that
is barely in vivo and is very different than reversing colon cancer in a
mouse.
Stuart LaForge
More information about the extropy-chat
mailing list